by Virology Research Services | May 30, 2019 | Virus of the Month
From concept to reality: How a virus is helping to advance gene therapy This month the FDA approved Zolgensma (Novartis), the first gene therapy for spinal muscular atrophy in children. While the treatment price – $2.125 million – is making most headlines, here we...
